AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2022
Oct 20, 2022
33194_dirs_2022-10-20_ca988a20-0e24-4fc4-b352-3aa0c361fa43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-10-18
Reporting Person: LACOB JOSEPH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-10-18 | Common Stock | M | 192 | $0.026 | Acquired | 384 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-10-18 | Stock Option (Rt to Buy) | $0.026 | M | 192 | Disposed | 2022-11-12 | Common Stock (192) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 351728 | Indirect |
Footnotes
F1: Includes 128,174 shares held by Lacob Ventures LLC and 223,554 shares held by LCT18 Investments, LLC.
F2: The share underlying the option are fully vested.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23